Mustafa Munye

Director R&D Operations • Complement Therapeutics

Mustafa Munye, Ph.D has 10+ years in the discovery and development of ATMP’s. He has led process and analytical development for AAV gene therapies, CAR-T and PSC-derived cell therapies to support first-in-human studies. Mustafa is currently director of R&D Operations at Complement Therapeutics whose lead program is an AAV gene therapy.

Also speaking

Kinnari Patel

Chief Operating Officer • Rocket Pharma

Sven Kili

Chief Executive Officer • Antion

Joel Eichmann

Co-Founder • Green Elephant Biotech

Event Info


Sponsorship Brochure

Take a look at the 2023 sponsorship opportunities here.

Agenda at a Glance

Check out the Agenda at a Glance for Advanced Therapies Europe 2023.